AIM
MRNA icon

Artemis Investment Management’s Moderna MRNA Stock Holding History

Artemis Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75,515
Closed -$13M – 278
2022
Q1 		$13M Buy
75,515
+15,869
+27% +$2.67M 0.1% 169
2021
Q4 		$15.1M Buy
59,646
+1,298
+2% +$380K 0.11% 165
2021
Q3 		$22.4M Buy
+58,348
New +$21.5M 0.18% 144

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artemis Investment Management's MRNA Position: Q2 2022 in Review

Artemis Investment Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 75,515 shares — an estimated $13M sold.

Artemis Investment Management first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $22.4M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Artemis Investment Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Artemis Investment Management sold 75,515 Moderna shares in Q2 2022, an estimated $13M.
  • Artemis Investment Management first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Artemis Investment Management's Moderna position peaked at $22.4M in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Artemis Investment Management's 13F filing for Q2 2022, filed 22 Jul 2022.